Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report - Top-Institutions - MDSpire

Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report

  • By

  • Longmei Chen

  • Wanchao Liu

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Abramson Cancer Center, University of Pennsylvania
    Abramson Cancer Center, University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Hematology
    • Oncology

  • #4

    Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia

    Philadelphia, PA

    Key Differentiators

    • Pediatric Hematology
    • Oncology

  • #5

    Centre Henri Becquerel
    Centre Henri Becquerel

    Rouen, France

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report

  • by Longmei Chen, Wanchao Liu

  • July 14, 2026

Related Content

Transformation from lung adenocarcinoma to pulmonary giant cell carcinoma following targeted therapy: a case report

Postoperative radiotherapy for resected esophageal squamous cell carcinoma: a systematic review and meta-analysis

Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma